GLP-1 receptor agonists in adolescent obesity: Incretin-based therapies during a sensitive developmental period
{{output}}
Adolescent obesity is a chronic disease associated with early cardiometabolic dysfunction and long-term health risk. Behavioral interventions alone produce modest and unsustained weight loss, leading to increasing use of pharmacotherapy. Glucagon-like peptide-... ...
